Sk alleged that she was in moses h cone hospital as a patient from (b)(6) through (b)(6) 2020.She stated she has type 1 diabetes and was on glucostabilizer during her stay and that she went into diabetic ketoacidosis (dka) 2 times.Initial investigation showed that glucostabilizer did not malfunction; the multiplier and calculated insulin infusion rates performed per the algorithm and the configured settings by moses cone.All configuration settings appeared appropriate.The glucose entries appeared timely.The blood glucose values entered into glucostabilizer for sk were not typical for dka, however euglycemic (near normal or mildly elevated blood glucose levels) dka can occur.After speaking with the client, moses cone, it was learned that sk was hospitalized with a diagnosis of dka and prior to the dka admission sk medication regimen included a sodium-glucose cotransporter (sglt) inhibitor.
|